drugset / Trial / NCT03035955

Azelaic Acid on Demodex Counts in Rosacea

NCT03035955

Phase 2/3 Completed 20 enrolled Wake Forest University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to measure the effects of azelaic acid on Demodex folliculorum counts and disease condition via a split face design in approximately twenty patients with mild to moderate rosacea. The investigators hypothesize that treatment of rosacea with azelaic acid will lead to a decreased Demodex folliculorum count as well as an improvement in lesion count and redness.

Timeline

Start
2010-12
Primary completion
2012-02-02
Completion
2012-02-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelaic acid Small molecule 15 % Topical

Indications